CEO Lori Woods discusses the impact of Cesium-131 with Big Biz TV

Jul 9, 2020

In a recent conversation with Big Biz TV, CEO Lori Woods talked with Big Biz TV about Isoray’s important role in the war on cancer and the difference Cesium-131 internal radiation therapy is making in treating prostate and hard to treat cancers including brain, lung, and head and neck cancers.

Investor Relations:

Mark Levin

Global IR Group
(501) 255-1910

Media and Public Relations:

Sharon Schultz
Schultz Public Relations
(302) 539-3747

Isoray, Inc. Announces Proposed Underwritten Public Offering

RICHLAND, Wash., October 19, 2020 -- Isoray, Inc. (NYSE AMERICAN: ISR) (“Isoray” or the “Company”), a medical technology company and innovator in seed brachytherapy powering expanding treatment options throughout the body, today announced that it intends to offer and...

read more